Drug intelligence / Profile preview

Cevac IBron

Development stage: Unknown
Lead developer: Ceva Animal Health
Modality: Vaccines & Immunotherapeutics
Administration: Oral, Inhalation

Overview

Cevac IBron is a live attenuated monovalent veterinary vaccine developed by Ceva Animal Health for the immunization of poultry against avian infectious bronchitis. The vaccine contains a live attenuated infectious bronchitis virus (IBV) of the Georgia (GA) serotype. It is specifically designed to provide protection against multiple variant strains of IBV, including GA08, GA13, and DMV/1639/11. Indicated for healthy chickens at one day of age or older, it is administered via coarse spray or oral gel droplets. The vaccine aims to reduce broiler mortality, antibiotic usage, and respiratory-related condemnations at slaughter by preventing respiratory infections caused by these specific IBV variants.

Brand names: Cevac IBron

Beyond the preview

Go deeper on Cevac IBron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cevac IBron.

Explore the full profile